cbdMD (YCBD) Cost of Revenue (2016 - 2026)

cbdMD has reported Cost of Revenue for 10 years, with the latest figure at $2.0 million in Q4 2025.

• Quarterly Cost of Revenue rose 17.67% year-over-year to $2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.5 million (up 1.94% YoY) and the FY2025 annual result came in at $7.2 million, down 3.53% from the prior year.
• Cost of Revenue climbed to $2.0 million in Q4 2025 per YCBD's latest filing, from $1.9 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $4.3 million in Q4 2021 and troughed at $1.7 million in Q4 2024.
• A 5-year average of $2.5 million and a median of $2.2 million in 2023 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2021 and 2022: Cost of Revenue surged 33.35% in 2021, then sank 41.84% in 2022.
• Over 5 years, Cost of Revenue stood at $4.3 million in 2021, then tumbled by 41.84% to $2.5 million in 2022, then retreated by 27.79% to $1.8 million in 2023, then decreased by 5.78% to $1.7 million in 2024, then grew by 17.67% to $2.0 million in 2025.
• According to Business Quant data, Cost of Revenue over the past three periods registered $2.0 million, $1.9 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.